110 results
8-K
EX-99.1
RKDA
Arcadia Biosciences Inc
28 Mar 24
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights
5:02pm
Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about the company
8-K
EX-99.1
RKDA
Arcadia Biosciences Inc
9 Nov 23
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2023
4:10pm
-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about the company and its products, including statements
8-K
EX-99.1
gmvrivmjsx9ps3ga07
10 Aug 23
Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2023 Financial Results and Business Highlights
4:19pm
8-K
g4ndgx8ry
20 Jul 23
Arcadia Biosciences (RKDA) Announces Strategic Review
2:55pm
8-K
EX-99.1
et8cuf 61940g2n
20 Jul 23
Arcadia Biosciences (RKDA) Announces Strategic Review
2:55pm
8-K
EX-99.1
8mmczu0ps2
11 May 23
Arcadia Biosciences (RKDA) Announces First Quarter 2023
4:26pm
8-K
EX-99.1
50irj
30 Mar 23
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights
4:07pm
8-K
EX-99.1
zx44xa0699n oe0vpfxj
30 Nov 22
Arcadia Biosciences (RKDA) Announces CFO Transition
4:32pm
8-K
EX-99.1
264tdnner3pkm816
10 Nov 22
Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2022
4:11pm
8-K
EX-99.1
0wv9qy
16 Aug 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
2o014flgf0ne16 mg2
16 Aug 22
Entry into a Material Definitive Agreement
5:00pm
424B5
550lfq
16 Aug 22
Prospectus supplement for primary offering
9:44am